A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin (PAINS)

Viatris

Status: Completed

Conditions: Neuropathic Pain

Treatments: Drug: Pregabalin

Study type: Observational

Funder types: Industry

Identifiers

NCT00892008

A0081094

Details and patient eligibility

About

This study is being conducted as a regulatory requirement post initial marketing authorization. This is primarily a safety study. This was an open label study and patients were enrolled once the decision to prescribe the medication was made by the Investigator.

Enrollment: 2,278 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female, 18 years old and above diagnosed with neuropathic pain.

Exclusion criteria

• Patients that are pregnant and lactating; and patients with known hypersensitivity to pregabalin or its related components.

Trial design

2,278 participants in 1 patient group

Open-Label

Description:

This study was open-label with only one treatment group. Pregabalin was prescribed in accordance with usual clinical practice.

Treatment:

Drug: Pregabalin